Fate Therapeutics Inc
Biotechnology company · San Diego, California, United States · Nasdaq: FATE
Fate Therapeutics Inc is a biotechnology company headquartered in San Diego, California, United States. Its earliest recorded incorporation is in 2007. Its shares trade on Nasdaq under the ticker FATE. It has reported private securities offerings to the US SEC, most recently $50 million sold in a notice filed in 2020.
Fate Therapeutics at a glance
What does Fate Therapeutics do?
Private fundraising reported to the SEC
11 Form D notices; the most recent reported $50 million sold (2020).
Frequently asked questions about Fate Therapeutics
Where is Fate Therapeutics headquartered?
Fate Therapeutics Inc is headquartered in San Diego, California, United States.
What does Fate Therapeutics do?
Fate Therapeutics Inc is a biotechnology company. Its SEC industry classification is Biological Products, (No Diagnostic Substances).
Is Fate Therapeutics a public company?
Yes. Fate Therapeutics Inc trades on Nasdaq under the ticker FATE.
When was Fate Therapeutics founded?
The earliest incorporation on record for Fate Therapeutics Inc is in 2007, according to public company registers.
Similar companies
- Biolinq IncSan Diego, California, United States
- BioAtla, Inc.San Diego, California, United States
- Neurocrine Biosciences IncSan Diego, California, United States
- ImmunityBio, Inc.San Diego, California, United States
- Sorrento Therapeutics, Inc.San Diego, California, United States
- Protego Biopharma, Inc.San Diego, California, United States
- Tempo Therapeutics, Inc.San Diego, California, United States
- ImageneBio, Inc.San Diego, California, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesSources
Location data: GeoNames (geonames.org), CC BY 4.0.
Last updated 2026-09-23.